カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の子宮頸がん診断市場2023-2030：検査種類別（パップテスト/細胞診検査、HPV検査、コルポスコピー、子宮頸部生検）、年齢層別、エンドユーザー別、地域別

【英語タイトル】Cervical Cancer Diagnostic Market Size, Share & Trends Analysis Report By Test Type (Pap Testing Or Cytology Testing, HPV Testing, Colposcopy, Cervical Biopsies), By Age Group, By End Use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV070）・商品コード：GRV23NOV070
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：100
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

子宮頸がん診断市場の成長と動向
Grand View Research, Inc.の最新調査によると、子宮頸がん診断の世界市場規模は2023年から2030年にかけて年平均成長率5.7%で推移し、2030年には70億米ドルに達する見込みです。主な推進要因は、子宮頸がんの有病率の上昇、スクリーニング技術の進化、定期検診とスクリーニングを促進するさまざまなプログラムなどです。WHOが発表したデータによると、2012年に子宮頸がんが原因で死亡した女性は27万人を超え、その大半は発展途上国の女性でした。子宮頸がんは、女性に最も多く診断されるがんのひとつです。子宮頸がんは、女性のがんの中で最も多く診断されるものの1つであり、その病因としては、複数のセックスパートナー、飲酒や喫煙などのライフスタイルの変化、ストレスの増加などが挙げられます。

さらに、政府の積極的な取り組みや啓発プログラムの増加が、今後数年間の市場成長を促進すると期待されています。全米子宮頸がん連合、WHO、CDC、米国予防サービス作業部会は、中高年女性の子宮頸がん早期検診の必要性を推進するために取り組んでいます。

疾患の早期介入を促進する技術的に高度な診断手順への需要が高まっています。業界各社は、正確で効率的な結果を得るための革新的な技術ソリューションの開発に注力しています。バイオマーカーの使用など、スクリーニング技術の進歩が重要性を増しています。技術開発の急増は、業界の成長をさらに促進すると予想されます。

子宮頸がんによる死亡者数は、パップテストの普及により、ここ数年で大幅に減少しています。パップテストは、前がん病変を早期に発見するのに役立つため、子宮頸がんの患者数を減らすことができます。米国癌協会によると、米国では過去40年間に子宮頸癌の症例が50％以上減少したとのことです。当初、パップテスト検診は毎年実施され、不必要な処置が行われていました。しかし、現在、米国癌協会は、21歳から29歳の女性は3年ごとにパップテストを受けることを推奨しています。

子宮頸がん診断市場レポートハイライト

- 2022年の市場シェアは、パップテスト分野が33.06%と大半を占めました。このセグメントの大きなシェアは、早期診断における検査の高い効率性に起因しています。また、早期診断の影響に対する意識の高まりも、同分野の成長に寄与しています。

- 2022年には、北米が45.74%の収益シェアで地域市場をリードしていました。北米の主要市場は米国でした。子宮頸がんの罹患率の増加と、早期検診に関連する意識向上プログラムの形で政府機関が実施する取り組みが、同国の市場シェアが高い主な要因です。

- アジア太平洋地域は、予測期間中CAGR 8.6％で成長し、有利な成長が見込まれています。インド、中国、フィリピンなどの発展途上国の政府が、医療インフラを改善し、医療施設へのアクセスを向上させるためにさまざまな措置を講じていることが、この地域の高成長の主な要因のひとつです。また、発展途上国における癌の有病率の高さ、消費者の意識レベルの向上も成長の原動力となっています。

- この市場は現在、Becton, Dickinson and Company、F. Hoffmann-La Roche Ltd、Abbott Laboratories、OncoHealth Corp、Hologic, Inc.、QIAGEN、Quest Diagnostics, Inc.、Guided Therapeutics, Inc.などの主要参入企業によって支配されています。主要企業は、診断のための革新的なソリューションの開発に特に注力しています。例えば、F. Hoffmann-La Roche Ltd.は2014年に、前癌細胞の存在を効率的に検出する自動CINtec PLUS細胞診検査を発売しました。

第1章 調査方法・範囲
第2章 エグゼクティブサマリー
第3章 世界の子宮頸がん診断市場変数・傾向・範囲
第4章 世界の子宮頸がん診断市場：検査種類別予測・傾向分析
第5章 世界の子宮頸がん診断市場：年齢層別予測・傾向分析
第6章 世界の子宮頸がん診断市場：エンドユーザー別予測・傾向分析
第7章 世界の子宮頸がん診断市場：地域別予測・傾向分析
第8章 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Test Type
1.1.2. Age group
1.1.3. End use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test Type outlook
2.2.2. Age group outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Cervical Cancer Diagnostic Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. The increasing demand for cervical cancer screening tools
3.4.1.2. Increase in cervical cancer cases across the globe
3.4.1.3. Technological advancements
3.4.2. Market restraint analysis
3.4.2.1. Limited number of approved products
3.4.2.2. Complications/risks associated with microneedles
3.5. Cervical Cancer Diagnostic Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Cervical Cancer Diagnostic Market: Test Type Estimates & Trend Analysis
4.1. Cervical Cancer Diagnostic Market, By Test Type Key Takeaways
4.2. Cervical Cancer Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Pap Testing
4.3.1. Pap testing market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. HPV Testing
4.4.1. HPV testing market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Colposcopy
4.5.1. Colposcopy market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Cervical Biopsies
4.6.1. Cervical biopsies market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Cystoscopy
4.7.1. Cystoscopy market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Cervical Cancer Diagnostic market: Age group Estimates & Trend Analysis
5.1. Cervical Cancer Diagnostic Market, By Age group Key Takeaways
5.2. Cervical Cancer Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
5.3. 20-40 years
5.3.1. 20-40 years market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Above 40 years
5.4.1. Above 40 years market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Cervical Cancer Diagnostic market: End Use Estimates & Trend Analysis
6.1. Cervical Cancer Diagnostic Market, By End Use Key Takeaways
6.2. Cervical Cancer Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals
6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Laboratories
6.4.1. Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Diagnostic Centers
6.5.1. Diagnostic centers market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Cervical Cancer Diagnostic Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Cervical Cancer Diagnostic Market by Region: Key Marketplace Takeaway
7.3. North America
7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.6. Sweden
7.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.7. Norway
7.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.8. Denmark
7.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. Saudi Arabia
7.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.2. South Africa
7.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Abbott Laboratories
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Ouigan NV
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Thermo Fisher Scientific Inc
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Dickinson and Company
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Hologic Inc
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. CooperSurgical Inc
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Siemens Healthineers
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 3 North America cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 4 North America cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 5 North America cervical cancer diagnostic market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 7 U.S. cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 8 U.S. cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 9 Canada cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 10 Canada cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 11 Canada cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 12 Europe cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 13 Europe cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 14 Europe cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 15 Europe cervical cancer diagnostic market, by region, 2018 - 2030 (USD Million)
Table 16 Germany cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 17 Germany cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 18 Germany cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 19 UK cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 20 UK cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 21 UK cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 22 France cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 23 France cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 24 France cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 25 Italy cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 26 Italy cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 27 Italy cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 28 Spain cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 29 Spain cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 30 Spain cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 31 Sweden cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 32 Sweden cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 33 Sweden cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 34 Norway cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 35 Norway cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 36 Norway cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 37 Denmark cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 38 Denmark cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 39 Denmark cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 41 Asia Pacific cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 42 Asia Pacific cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific cervical cancer diagnostic market, by region, 2018 - 2030 (USD Million)
Table 44 China cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 45 China cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 46 China cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 47 Japan cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 48 Japan cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 49 Japan cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 50 India cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 51 India cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 52 India cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 53 Thailand cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 54 Thailand cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 55 Thailand cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 56 South Korea cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 57 South Korea cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 58 South Korea cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 59 Latin America cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 60 Latin America cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 61 Latin America cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 62 Latin America cervical cancer diagnostic market, by region, 2018 - 2030 (USD Million)
Table 63 Brazil cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 64 Brazil cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 65 Brazil cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 66 Mexico cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 67 Mexico cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 68 Mexico cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 69 Argentina cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 70 Argentina cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 71 Argentina cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 72 Middle East and Africa cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 73 Middle East and Africa cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 74 Middle East and Africa cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa cervical cancer diagnostic market, by region, 2018 - 2030 (USD Million)
Table 76 South Africa cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 77 South Africa cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 78 South Africa cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 79 Saudi Arabia cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 80 Saudi Arabia cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 82 UAE cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 83 UAE cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 84 UAE cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 85 Kuwait cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
Table 86 Kuwait cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
Table 87 Kuwait cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Cervical cancer diagnostic: Market outlook
Fig. 9 Cervical cancer diagnostic: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Cervical cancer diagnostic market driver impact
Fig. 15 Cervical cancer diagnostic market restraint impact
Fig. 16 Cervical cancer diagnostic market strategic initiatives analysis
Fig. 17 Cervical cancer diagnostic market: Test Type movement analysis
Fig. 18 Cervical cancer diagnostic market: type outlook and key takeaways
Fig. 19 Pap testing market estimates and forecasts, 2018 - 2030
Fig. 20 HPV testing market estimates and forecasts, 2018 - 2030
Fig. 21 Colposcopy market estimates and forecasts, 2018 - 2030
Fig. 22 Cervical biopsies market estimates and forecasts, 2018 - 2030
Fig. 23 Cytoscopy market estimates and forecasts, 2018 - 2030
Fig. 24 Cervical cancer diagnostic market: Age-group movement analysis
Fig. 25 Cervical cancer diagnostic market: age-group outlook and key takeaways
Fig. 26 20-40 years market estimates and forecasts, 2018 - 2030
Fig. 27 Above 40 years market estimates and forecasts, 2018 - 2030
Fig. 28 Cervical cancer diagnostic market: End use movement analysis
Fig. 29 Cervical cancer diagnostic market: end use outlook and key takeaways
Fig. 30 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 31 Laboratories market estimates and forecasts, 2018 - 2030
Fig. 32 Diagnostic centers management market estimates and forecasts, 2018 - 2030
Fig. 33 Global Cervical cancer diagnostic market: Regional movement analysis
Fig. 34 Global Cervical cancer diagnostic market: regional outlook and key takeaways
Fig. 35 North America market estimates and forecasts, 2018 - 2030
Fig. 36 U.S. market estimates and forecasts, 2018 - 2030
Fig. 37 Canada market estimates and forecasts, 2018 - 2030
Fig. 38 Europe market estimates and forecasts, 2018 - 2030
Fig. 39 UK market estimates and forecasts, 2018 - 2030
Fig. 40 Germany market estimates and forecasts, 2018 - 2030
Fig. 41 France market estimates and forecasts, 2018 - 2030
Fig. 42 Italy market estimates and forecasts, 2018 - 2030
Fig. 43 Spain market estimates and forecasts, 2018 - 2030
Fig. 44 Sweden market estimates and forecasts, 2018 - 2030
Fig. 45 Norway market estimates and forecasts, 2018 - 2030
Fig. 46 Denmark market estimates and forecasts, 2018 - 2030
Fig. 47 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 48 Japan market estimates and forecasts, 2018 - 2030
Fig. 49 China market estimates and forecasts, 2018 - 2030
Fig. 50 India market estimates and forecasts, 2018 - 2030
Fig. 51 Australia market estimates and forecasts, 2018 - 2030
Fig. 52 Thailand market estimates and forecasts, 2018 - 2030
Fig. 53 South Korea market estimates and forecasts, 2018 - 2030
Fig. 54 Latin America market estimates and forecasts, 2018 - 2030
Fig. 55 Brazil market estimates and forecasts, 2018 - 2030
Fig. 56 Mexico market estimates and forecasts, 2018 - 2030
Fig. 57 Argentina market estimates and forecasts, 2018 - 2030
Fig. 58 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 59 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 60 South Africa market estimates and forecasts, 2018 - 2030
Fig. 61 UAE market estimates and forecasts, 2018 - 2030
Fig. 62 Kuwait market estimates and forecasts, 2018 - 2030

★調査レポート[世界の子宮頸がん診断市場2023-2030：検査種類別（パップテスト/細胞診検査、HPV検査、コルポスコピー、子宮頸部生検）、年齢層別、エンドユーザー別、地域別] (コード：GRV23NOV070)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の子宮頸がん診断市場2023-2030：検査種類別（パップテスト/細胞診検査、HPV検査、コルポスコピー、子宮頸部生検）、年齢層別、エンドユーザー別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のHPV検査＆パップテスト市場2021-2031：検査種類別（HPV検査、パップテスト、同時検査）、用途別、検査場所別
  • 世界の膵臓がん診断市場2023-2030：製品別、検査種類別（イメージング検査、生検、血液検査、その他）、がん種類別（外分泌、内分泌）、エンドユーザー別、地域別
  • 世界の結核診断市場（2023-2030）：検査種類別（放射線法、臨床検査法、核酸検査、ファージアッセイ）、エンドユーザー別、地域別
  • 世界のHIV診断市場2023-2030：製品別（消耗品、機器）、検査種類別（抗体検査、ウイルス負荷検査）、モード別（自己検査、研究所ベース）、エンドユーザー別、地域別
  • 世界の前立腺がん診断市場（～2027）：検査種類別、年齢層別、エンドユーザー別、地域別
  • 世界の心不全用POC・LOC機器市場2023-2030：検査種類別、技術別（マイクロ流体、アレイベースシステム）、エンドユーザー別（診療所、病院、生活支援医療施設）、地域別
  • HPV検査＆パップテストの世界市場2023-2030：市場規模、シェア、動向分析
  • HPV検査＆パップテストの世界市場2023-2030：市場規模、シェア、動向分析

    • ◆H&Iグローバルリサーチのお客様（例）◆